Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound sodium acetate glucose injection for perioperative rehabilitation in lower abdominal surgery under general anesthesia
ChiCTR2500100564Phase 4Not yet recruiting
- Sponsor
- Zhongda Hospital, Southeast University
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of compound sodium acetate and glucose injection (2 arms), sponsored by Zhongda Hospital, Southeast University. Primary endpoint: EQ-5D-5L Health scale score. Planned start May 2024; status: not yet recruiting.
02
Drugs
compound sodium acetate and glucose injection
Beyond the preview
Go deeper on ChiCTR2500100564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500100564.